Rep. Rush Holt speaking for his 2/25 anthrax investigation amendment

William Broad and Scott Shane have written a very useful NYT piece on the anthrax letters.  It discusses a new academic paper by Martin Hugh-Jones, Stuart Jacobsen and Barbara hatch Rosenberg, which explores the meaning of the tin and silicon found in the anthrax spore preparation of the anthrax letters. A decade after wisps of anthrax…

I discovered the following 3 year old conference presentation on the internet. Information on this syndrome has not been published in the medical literature, nor is information about it available on the VHC website. The recorded presentation is of great interest. Thursday, May 13, 2004 – 11:45 AM5034 Reproducible Prolonged Myalgia Syndrome (RPMS) Following Multiple…

per CDC: Dropping from a peak of over 50% positive swine flu tests, we had only 2% positive the week of Dec 1,2009. Approximately 98% of those with respiratory infections who were tested then for swine flu had something else. And since CDC has only advised testing severe cases, we can safely assume that under…

I hope you have noticed that while the mass media have spent 2 months railing about the dangers of hydroxychloroquine and how it may kill you, they have had a hard time finding doctors to issue the alarm on-camera.  Practicing doctors usually know that the risks of HCQ are no greater than the risk of…

This HHS chart indicates that vaccine will be distributed in early November, after which “monitoring effectiveness and safety” begins. Here is an excellent H1N1 swine flu links page from the National Library of Medicine. This DHHS/DHS document explains the plan for priority targeting of (pandemic) influenza vaccinations. According to FDA: Through an Emergency Use Authorization…

I discussed multiple topics, including: 1.  markedly increased mortality rates seen in heavily vaccinated countries, 2.  the coordinated rollout of new untested boosters throughout the EU, Switzerland, UK, Canada and the US on virtually the same day,  3.  negative vaccine efficacy, 4.  the poor vaccine efficacy that did not just start with omicron 5.  regulatory…